Cargando…

Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease

Cyclic peptidomimetic compounds have been investigated utilizing ab initio Hartree Fock molecular orbital calculations. Prospective use of these ionophores as curative drugs for Alzheimer’s disease has been investigated by considering their metal toxicity removal efficiency. A (2,4,2,4) system that...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Antara, Yadav, Arpita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Master Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615259/
https://www.ncbi.nlm.nih.gov/pubmed/23675196
_version_ 1782264991621054464
author Banerjee, Antara
Yadav, Arpita
author_facet Banerjee, Antara
Yadav, Arpita
author_sort Banerjee, Antara
collection PubMed
description Cyclic peptidomimetic compounds have been investigated utilizing ab initio Hartree Fock molecular orbital calculations. Prospective use of these ionophores as curative drugs for Alzheimer’s disease has been investigated by considering their metal toxicity removal efficiency. A (2,4,2,4) system that is, ((gly-et)-(ala-gly-gly-et))(2) with CH(2)NH backbone is predicted to undergo low conformational reorganization in presence of Zn(2+) ion with moderate electrostatic stabilization of ion. Conformation of this system and molecular weight render it suitable to be a lead compound for metal toxicity removal drugs required in AD.
format Online
Article
Text
id pubmed-3615259
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Master Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36152592013-05-01 Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease Banerjee, Antara Yadav, Arpita Int J Biomed Sci Article Cyclic peptidomimetic compounds have been investigated utilizing ab initio Hartree Fock molecular orbital calculations. Prospective use of these ionophores as curative drugs for Alzheimer’s disease has been investigated by considering their metal toxicity removal efficiency. A (2,4,2,4) system that is, ((gly-et)-(ala-gly-gly-et))(2) with CH(2)NH backbone is predicted to undergo low conformational reorganization in presence of Zn(2+) ion with moderate electrostatic stabilization of ion. Conformation of this system and molecular weight render it suitable to be a lead compound for metal toxicity removal drugs required in AD. Master Publishing Group 2010-09 /pmc/articles/PMC3615259/ /pubmed/23675196 Text en © Antara Banerjee et al. Licensee Master Publishing Group http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Banerjee, Antara
Yadav, Arpita
Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
title Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
title_full Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
title_fullStr Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
title_full_unstemmed Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
title_short Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
title_sort cyclic peptidomimetic lead compounds to reduce neurotoxicity and associated oxidative stress in alzheimer’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615259/
https://www.ncbi.nlm.nih.gov/pubmed/23675196
work_keys_str_mv AT banerjeeantara cyclicpeptidomimeticleadcompoundstoreduceneurotoxicityandassociatedoxidativestressinalzheimersdisease
AT yadavarpita cyclicpeptidomimeticleadcompoundstoreduceneurotoxicityandassociatedoxidativestressinalzheimersdisease